logo

Sea Horse brand Easy Peel Shrimp recalled due to undeclared sulphites Français

Cision Canada2 days ago
OTTAWA, ON, July 12, 2025 /CNW/ -
Product: Easy Peel Shrimp
Issue: Food - Allergen - Sulphites
Distribution: Quebec
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trans Canada Trail Challenges Canadians to Collectively Cover 30,000 KM in 30 Days Français
Trans Canada Trail Challenges Canadians to Collectively Cover 30,000 KM in 30 Days Français

Cision Canada

timean hour ago

  • Cision Canada

Trans Canada Trail Challenges Canadians to Collectively Cover 30,000 KM in 30 Days Français

The Great Canadian Hike invites participants to hike, bike, paddle or roll to raise funds for the world's longest trail system OTTAWA, ON, July 14, 2025 /CNW/ - 30,000 kilometres in 30 days. That's the ambitious goal behind an initiative being launched by Trans Canada Trail. Registration is now open for The Great Canadian Hike, a national challenge that invites people of all ages and abilities to get active in support of Canada's nationwide trail system. From Sept. 20 to Oct. 19, people across the country will be hiking, biking, paddling and rolling on their section of the Trans Canada Trail, logging their distances to collectively cover 30,000 kilometres, the approximate length of the Trail, in 30 days. How it works: All funds raised directly support the Trans Canada Trail, including critical projects like trail maintenance, greenway development, climate resilience efforts and accessibility upgrades. "Every kilometre of the Trans Canada Trail has the power to inspire and bring us together and I invite everyone to join the Great Canadian Hike to experience that power firsthand," says Mathieu Roy, Chief Executive Officer of Trans Canada Trail. "This challenge is about more than raising funds and logging kilometres, it's about forging meaningful connections with nature and our nationwide community. The Trail is a truly national, multi-generational project and when we come together to support it, we are protecting an essential part of who we are as Canadians." Why this challenge matters: Spanning nearly 30,000 kilometres and touching every province and territory, the Trans Canada Trail connects thousands of communities and reaches more than 80% of Canadians within 30 minutes of where they live. A 2023 study showed the Trail delivers significant benefits, including: $23.1 billion in economic activity $1.7 billion in public health impact $82 million in environmental benefits Canadians agree: 94% say trails are essential for accessing nature 92% use trails to support their mental health 91% value trails as a free, accessible way to stay active The Great Canadian Hike is generously supported by Athletic Brewing Company, a long-time champion for trails and access to the outdoors, and Manulife, who is committed to helping Canadians live longer, healthier, better lives in alignment with their Impact Agenda. About Trans Canada Trail The Trans Canada Trail is the longest multi-use trail system in the world and it is always growing. It reaches every province and territory and connects all three of Canada's coastlines. Each section of the Trans Canada Trail is managed locally and supports different activities and community needs. Trans Canada Trail is the organization that advocates for, stewards and champions Canada's nationwide trail system. It is a registered charity that receives funding from the Government of Canada (through Parks Canada), various provincial and municipal governments, and generous donors.

Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot

Cision Canada

time7 hours ago

  • Cision Canada

Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot

Clinical study in Scientific Reports shows Bridge Capture™ detects key mutations from blood samples in metastatic colorectal cancer patients TURKU, Finland, July 14, 2025 /CNW/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published in Scientific Reports, demonstrating the high sensitivity of its Bridge Capture™ technology for mutation profiling in cell free DNA of metastatic colorectal cancer patients. Study shows that Bridge Capture™ matches the sensitivity of droplet digital PCR (ddPCR) - a gold standard in the field - while providing unlimited panel scalability and simple and cost-efficient workflow that enables decentralized NGS testing. The study was performed in collaboration with professor Ari Ristimäki's group (Helsinki University Hospital) and demonstrated a high concordance of Bridge Capture™ to ddPCR and Ion AmpliSeq™ while revealing several other, previously unknown oncogenic mutations that reflected disease progression across longitudinal plasma samples. Prof. Ristimäki was impressed by Bridge Capture™'s capability to combine highly scalable, sensitive targeted sequencing with cost-efficiency and ease of use. He sees this as an important advance that could significantly expand the use of liquid biopsies in treatment monitoring. "Bridge Capture matched or exceeded gold-standard methods in detecting mutations in patient samples. Its ability to track changes over time could be a powerful tool for monitoring cancer progression and relapse." said Simona Adamusová, Doctoral Researcher and co-first author. "This clinical pilot study highlights Bridge Capture's readiness for real-world applications in liquid biopsy," added Manu Tamminen, CEO and Co-Founder of Genomill. "The unparalleled simplicity of the laboratory workflow and the compatibility across multiple sequencing platforms lays ground for distributed, decentralized, longitudinal cancer diagnostics. By removing cost and infrastructural constraints that currently hinder the routine use of liquid biopsies, we seek to establish Bridge Capture as an enabling technology for highly accessible cancer diagnostics." Bridge Capture™ is an embodiment of Genomill's Geno1 ® technologies that are based on circular DNA and linear DNA amplification. Juha-Pekka Pursiheimo, CTO and inventor of the technology, added: "Bridge Capture establishes a new standard for NGS library design by using circular single-stranded DNA - a more flexible and robust alternative to traditional linear libraries. Together with our PCR-free DNA amplification approaches, this positions Genomill to revolutionize NGS library preparation." The full study, titled "Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients", is available in Scientific Reports (link Contact CEO Manu Tamminen [email protected] Tel: +358403513712

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store